Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Iannetta and Loredana Sarmati.
Marco Iannetta
Connection Strength
3.032
Loredana Sarmati
  1. T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Mult Scler Relat Disord. 2021 Oct; 55:103157.
    View in: PubMed
    Score: 0.957
  2. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study. Sci Rep. 2021 06 17; 11(1):12762.
    View in: PubMed
    Score: 0.951
  3. Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab. Mult Scler Relat Disord. 2020 Oct; 45:102442.
    View in: PubMed
    Score: 0.896
  4. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine. 2021 Apr; 66:103341.
    View in: PubMed
    Score: 0.059
  5. Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. Life (Basel). 2020 Nov 23; 10(11).
    View in: PubMed
    Score: 0.057
  6. Depressive and anxiety symptoms in patients with SARS-CoV2 infection. J Affect Disord. 2021 01 01; 278:339-340.
    View in: PubMed
    Score: 0.056
  7. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020 08; 88:11-16.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.